The effect of a muscarinic receptor 1 gene variant on grey matter volume in schizophrenia

Vanessa L Cropley, Elizabeth Scarr, Alex Fornito, Paul Klauser, Chad Bousman, Rodney J Scott, Murray J Cairns, Paul A Tooney, Christos Pantelis, Brian Dean

Research output: Contribution to journalArticleResearchpeer-review

11 Citations (Scopus)


Previous research has demonstrated that individuals with schizophrenia who are homozygous at the c.267C>A single nucleotide polymorphism (rs2067477) within the cholinergic muscarinic M1 receptor (CHRM1) perform less well on the Wisconsin Card Sorting Test (WCST) than those who are heterozygous. This study sought to determine whether variation in the rs2067477 genotype was associated with differential changes in brain structure. Data from 227 patients with established schizophrenia or schizoaffective disorder were obtained from the Australian Schizophrenia Research Bank. Whole-brain voxel-based morphometry was performed to compare regional grey matter volume (GMV) between the 267C/C (N=191) and 267C/A (N=36) groups. Secondary analyses tested for an effect of genotype on cognition (the WCST was not available). Individuals who were homozygous (267C/C) demonstrated significantly reduced GMV in the right precentral gyrus compared to those who were heterozygous (267C/A). These preliminary results suggest that the rs2067477 genotype is associated with brain structure in the right precentral gyrus in individuals with schizophrenia/schizoaffective disorder. Future studies are required to replicate these results and directly link the volumetric reductions with specific cognitive processes
Original languageEnglish
Pages (from-to)182-187
Number of pages6
JournalPsychiatry Research: Neuroimaging
Issue number2
Publication statusPublished - 30 Nov 2015


  • schizophrenia
  • shizoaffective disorder
  • muscarinic M1 receptor (CHRM1)
  • single nucleotide polymorphism
  • voxel-based morphometry
  • imaging
  • set-shifting

Cite this